Comparison of Characteristics of Bronchoalveolar Lavage Dusting and of Specific Questionnary Data in Healthy Volunteers and Patients Suffering From Sarcoidosis
NCT ID: NCT02863406
Last Updated: 2016-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2014-02-28
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Blind analysis of bronchoalveolar lavage with Optical Microscopy, Transmission Electron Microscopy and MicroAnalysis.
For patients, comparison of bronchoalveolar lavage, pathological examination of biopsies (Optical Microscopy, Transmission Electron Microscopy and MicroAnalysis) and specific Professional and environmental questionnary.
Healthy volunteers matched with patients regarding to age (every 10 years), sex and tobacco consumption (non-smoking, smoking less than 5 pack-year, smoking between 5 and 10 pack-year, smoking more than 10 pack-year)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Lungs of Normal Individuals by Lung Lavage, Brushing and Bronchial Wall Biopsy
NCT00224185
Muscle Strength and Exercise Capacity in Sarcoidosis Patients
NCT00854672
Validation of a Non-invasive Diagnostic Method for Sarcoidosis Using Exhaled Breath
NCT02361281
Pharmacological Evaluation of Antifungal in Chronic Pulmonary Aspergillosis
NCT05064605
Bronchiectasis Effect in COPD Patients
NCT03670940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy volunteers
Bronchoalveolar lavage in healthy volunteers
Bronchoalveolar lavage
Bronchoalveolar lavage in order to determine rate of dust
Patients suffering from sarcoidosis
Bronchoalveolar lavage in patients suffering from sarcoidosis
Bronchoalveolar lavage
Bronchoalveolar lavage in order to determine rate of dust
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bronchoalveolar lavage
Bronchoalveolar lavage in order to determine rate of dust
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal spirometry and chest x-ray (healthy volunteers)
* Absence of viral infection (B and C hepatitis, HIV) (healthy volunteers)
* Confirmation of sarcoidosis (endoscopic exam with bronchoalveolar lavage) (patients suffering from sarcoidosis)
Exclusion Criteria
* Lack of bronchoalveolar lavage (volume less than 20 ml)
20 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sciences Po Paris
UNKNOWN
Centre Hospitalier Saint Joseph Saint Luc de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel Vincent, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Saint Joseph Saint Luc
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MINASARC01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.